Study of Inhaled Glucocorticosteroid Administration in Asthma Patients

Phase 4 Study of Once-Daily Inhaled Glucocorticosteroid Administration in Asthma Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00559689

Enrollment

Registered

2007-11-16

Start date

2005-11-30

Completion date

2007-03-31

Last updated

2009-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

asthma patients, well-controlled

Brief summary

Once-daily inhaled glucocorticosteroids treatment can sufficiently control airway inflammation in asthma patients.

Interventions

DRUGBudesonide,hydrofluoroalkane-beclomethasone dipropionate

receive twice-daily administration

DRUGBudesonide,hydrofluoroalkane-beclomethasone

once-daily administration at bedtime

Study design

Observational model

CASE_CROSSOVER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

20 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Receive ICS for one year or more, with no change in dose within the previous 8 weeks

Exclusion criteria

* Two or more courses of oral corticosteroid in the previous 12 months * Admission to hospital due to asthma in the previous 6 months * Admission to the intensive care unit due to asthma at any time in the past * Current cigarette smoker.

Design outcomes

Primary

Measure	Time frame
once-daily administration of inhaled glucocorticosteroids can control airway inflammation	two-year

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026